- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02962453
Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway in Patients After Knee Arthroplasty
June 30, 2017 updated by: Chang Ho Hwang, Ulsan University Hospital
Multi-Modalities Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway of the Proximal Muscles in Patients After Total Knee Arthroplasty
The aim of this study is to determine the clinical efficacy of gait rehabilitation robot through cortico-spinal-muscular pathway activation of the muscles remotely located from the end-effecter in patients after total knee arthroplasty.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
pre-interventional evaluation; within 1 day of intervention start primary end point; 3 days after intervention start secondary end point; 5 days after intervention start
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ulsan, Korea, Republic of, 682-714
- Ulsan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients after Unilateral Total Knee Arthroplasty
Exclusion Criteria:
- brain disease, spinal cord injury, peripheral neuropathy, myopathy
- Inability to ambulate fully due to muscukoskeletal disorders
- MMSE<23
- history of arthroplasty surgery on either of legs
- Cardiac pacemaker
- Refusal of participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Morning walk
Rehabilitation using end-effector type gait robot for 5days.
|
gait training with Morning walk three times during 5 minutes with 5 minute break a day over 5 weekdays
Other Names:
|
|
Active Comparator: Ground Walker
Rehabilitation using walker for 5days.
|
gait training with ground walker until corresponding 200 steps during 5 minutes with 5 minute break a day over 5 weekdays
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Isometric muscle strength
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
peak torque (Nm/㎡), Maximal ratio of torque development (RTD) (degree/sec)
|
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Cortico-motor Excitability
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
maximum & mean amplitude of peak to peak MEP (mV and mV), amplitude of peak to peak MEP/maximum M-wave (mV/mV)
|
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
|
Change of Spinal Motor-neuron Excitability
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
Peak to peak Max.
H-reflex (mV/mV), Peak to peak Max.
H-wave/Max.
M-reflex (mV/mV*㎡)
|
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
|
Change of Cross-sectional area and volume of thigh muscle
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
Cross-sectional area (c㎡) and and volume (cm3)
|
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
|
Change of Muscle work
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
peak and mean amplitude of CMAP (mV and mV) and mean area & total area of CMAP (c㎡/sec and c㎡/sec)
|
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2016
Primary Completion (Actual)
May 15, 2017
Study Completion (Actual)
May 15, 2017
Study Registration Dates
First Submitted
November 2, 2016
First Submitted That Met QC Criteria
November 8, 2016
First Posted (Estimate)
November 11, 2016
Study Record Updates
Last Update Posted (Actual)
July 2, 2017
Last Update Submitted That Met QC Criteria
June 30, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- chhwang6
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthroplasty, Replacement, Knee
-
Fondazione Don Carlo Gnocchi OnlusCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipItaly
-
Bornholms RegionskommuneCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipDenmark
-
Campus Bio-Medico UniversityRecruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipItaly
-
Sunnybrook Health Sciences CentreCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipCanada
-
SCRI Development Innovations, LLCWithdrawnArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
-
Haute Ecole de Santé VaudNot yet recruitingArthroplasty, Replacement, Hip | Arthroplasty Replacement, KneeSwitzerland
-
University of British ColumbiaThe Arthritis Society, Canada; Centre for Aging SMART; Centre for Advancing Health...Not yet recruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipCanada
-
University Hospital, Strasbourg, FranceRecruitingArthroplasty, Hip Replacement | Arthroplasty, Knee ReplacementFrance
-
Henry Ford Health SystemConsumer Sleep SolutionsNot yet recruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
Clinical Trials on Morning walk
-
Ulsan University HospitalMinistry of Health & Welfare, KoreaCompletedArthroplasty, Replacement, Knee | RoboticsKorea, Republic of
-
The University of Texas Medical Branch, GalvestonCompletedStroke | Healthy VolunteersUnited States
-
University of California, San FranciscoUniversity of California, BerkeleyCompleted
-
University of MinnesotaCompletedStress | AttentionUnited States
-
Joslin Diabetes CenterTerminatedDiabetes | Physical ActivityUnited States
-
University of WashingtonCompleted
-
Barretos Cancer HospitalUnknown
-
University GhentFlanders Marine InstituteCompleted
-
Istanbul UniversityCompletedMorbid ObesityTurkey
-
Rutgers, The State University of New JerseyRecruiting